The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Genomic characterization of locally recurrent prostate cancer after radiation therapy.
 
David Dewei Yang
No Relationships to Disclose
 
David Joseph Konieczkowski
No Relationships to Disclose
 
Andres Acosta
No Relationships to Disclose
 
Rosina Lis
Consulting or Advisory Role - Janssen Research & Development
Research Funding - Janssen Research & Development
Travel, Accommodations, Expenses - Janssen Research & Development
 
Filipe Lf Carvalho
No Relationships to Disclose
 
Brendan Michael Reardon
Patents, Royalties, Other Intellectual Property - institutional patents filed on methods for clinical interpretation
 
Jihye Park
No Relationships to Disclose
 
Kent William Mouw
Stock and Other Ownership Interests - Riva Therapeutics
Honoraria - OncLive/MJH Life Sciences; UpToDate
Consulting or Advisory Role - Riva Therapeutics; Urogen pharma
Research Funding - Pfizer
Patents, Royalties, Other Intellectual Property - Institutional patent filed on mutational signatures of DNA repair deficiency
 
Eliezer Mendel Van Allen
Stock and Other Ownership Interests - ervaxx; Genome Medical; Genomic Life; Manifold Bio; Microsoft; Monte Rosa Therapeutics; Syapse; Tango Therapeutics
Consulting or Advisory Role - ervaxx; Genome Medical; Genomic Life; Illumina; InVitae; Janssen; Manifold Bio; Monte Rosa Therapeutics; Novartis; Roche; Syapse; Takeda; Tango Therapeutics; Third Rock Ventures
Speakers' Bureau - Illumina
Research Funding - Bristol-Myers Squibb; Novartis; Sanofi (Inst)
Patents, Royalties, Other Intellectual Property - Patent on clinical interpretation algorithms using cancer molecular data (Inst); Patent on discovery of chromatin regulators as biomarkers of response to cancer immunotherapy (Inst); Patent on discovery of retained intron as source of cancer neoantigens (Inst)
Travel, Accommodations, Expenses - Roche/Genentech
 
Paul L. Nguyen
Stock and Other Ownership Interests - Volatilyx (I)
Consulting or Advisory Role - Bayer; Blue Earth Diagnostics; Boston Scientific; Janssen Oncology; Myovant Sciences
Research Funding - Astellas Pharma; Bayer; Janssen
Patents, Royalties, Other Intellectual Property - Wife has a patent on volatile diagnostics of infections (I)